Assessment of Food and Drug Administration– and European Medicines Agency–Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

IMPORTANCE: For patients with cancer treated with palliative intent, quality of life (QOL) is a critical aspect of treatment decision-making, alongside survival. However, regulatory approval can be based solely on survival measures or antitumor activities, without QOL evidence. OBJECTIVE: To investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arciero, Vanessa, Delos Santos, Seanthel, Koshy, Liza, Rahmadian, Amanda, Saluja, Ronak, Everest, Louis, Parmar, Ambica, Chan, Kelvin K. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879236/
https://www.ncbi.nlm.nih.gov/pubmed/33570573
http://dx.doi.org/10.1001/jamanetworkopen.2020.33004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879236/
https://www.ncbi.nlm.nih.gov/pubmed/33570573
http://dx.doi.org/10.1001/jamanetworkopen.2020.33004

Ejemplares similares